Skip to Main Content

Author Details

Martin K Schilling
University Hospital of Homburg/Saar (DE)
1990
268
40
PMIDPaper TitleJournal TitlePublished Year
36254526Deep, deep learning with BART.Magn Reson Med2023
36254526Deep, deep learning with BART.Magn Reson Med2023
27714521Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality-Swiss Group for Clinical Cancer Research Protocol SAKK 40/00.Int J Colorectal Dis2017
28631253Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.Clin Exp Metastasis2017
27714521Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality-Swiss Group for Clinical Cancer Research Protocol SAKK 40/00.Int J Colorectal Dis2017
28631253Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.Clin Exp Metastasis2017
27634764Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.Cancer Res2016
27634764Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.Cancer Res2016
23696206[Advance Directives - Not a Lot of Margin for Error - The Surgeon's View of a Complex Medical-Legal Topic].Zentralbl Chir2015
25772848Cilostazol improves hepatic blood perfusion, microcirculation, and liver regeneration after major hepatectomy in rats.Liver Transpl2015
25729916Proangiogenic potency of MUC18 in arteriosclerotic disease.J Cardiovasc Surg (Torino)2015
25811412Preconditioning by cilostazol protects against cold hepatic ischemia-reperfusion injury.Ann Transplant2015
25598073Isoflurane does not protect from brain death-associated aggravation of cold hepatic ischemia-reperfusion injury.Ann Transplant2015
26523932Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation.PLoS One2015
23696206[Advance Directives - Not a Lot of Margin for Error - The Surgeon's View of a Complex Medical-Legal Topic].Zentralbl Chir2015
26523932Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation.PLoS One2015
25729916Proangiogenic potency of MUC18 in arteriosclerotic disease.J Cardiovasc Surg (Torino)2015
25811412Preconditioning by cilostazol protects against cold hepatic ischemia-reperfusion injury.Ann Transplant2015
25772848Cilostazol improves hepatic blood perfusion, microcirculation, and liver regeneration after major hepatectomy in rats.Liver Transpl2015
25598073Isoflurane does not protect from brain death-associated aggravation of cold hepatic ischemia-reperfusion injury.Ann Transplant2015
23459788Liver injury following blunt abdominal trauma: a new mechanism-driven classification.Surg Today2014
24342081Hepatic resection of non-colorectal and non-neuroendocrine liver metastases - survival benefit for patients with non-gastrointestinal primary cancers - a case-controlled study.Int J Surg2014
24493023Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.Clin Exp Metastasis2014
23459788Liver injury following blunt abdominal trauma: a new mechanism-driven classification.Surg Today2014
25051901The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.Clin Exp Metastasis2014
25012086Darbepoetin-α accelerates neovascularization and engraftment of extrahepatic colorectal metastases.Eur Surg Res2014
25012086Darbepoetin-α accelerates neovascularization and engraftment of extrahepatic colorectal metastases.Eur Surg Res2014
25051901The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.Clin Exp Metastasis2014
24342081Hepatic resection of non-colorectal and non-neuroendocrine liver metastases - survival benefit for patients with non-gastrointestinal primary cancers - a case-controlled study.Int J Surg2014
24493023Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.Clin Exp Metastasis2014
22614231[Benchmarking surgical resources--a work sampling analysis at a German university hospital].Zentralbl Chir2013
22614231[Benchmarking surgical resources--a work sampling analysis at a German university hospital].Zentralbl Chir2013
23010854[Stroke always with an emergency physician? - Pro].Med Klin Intensivmed Notfmed2013
23859304Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: results of a randomized clinical pathway facilitated trial (NCT00998907).Surgery2013
23187934Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy.Clin Exp Metastasis2013
23517278Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature.Transpl Int2013
23242249Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases.Int J Colorectal Dis2013
23859304Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: results of a randomized clinical pathway facilitated trial (NCT00998907).Surgery2013
23517278Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature.Transpl Int2013
23187934Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy.Clin Exp Metastasis2013
23242249Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases.Int J Colorectal Dis2013
23010854[Stroke always with an emergency physician? - Pro].Med Klin Intensivmed Notfmed2013
21344368[Reduced time-frame for ward rounds and patient satisfaction].Zentralbl Chir2012
22650490Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation.Transpl Infect Dis2012
22438085Thyrotoxicosis after parathyroidectomy mimicking myocardial infarction: a case report and review of the literature.Clin Res Cardiol2012
22648175A comparative evaluation of ablations produced by high-frequency coagulation-, argon plasma coagulation-, and cryotherapy devices in porcine liver.Int J Colorectal Dis2012
22739241Hepatic arterial infusion with tumor necrosis factor-α induces early hepatic hyperperfusion.Eur Surg Res2012
22426638Estimate or calculate? How surgeons rate volumes and surfaces.Langenbecks Arch Surg2012
22526014Penetration of moxifloxacin into liver tissue.Int J Antimicrob Agents2012
22614682Normative values in anorectal manometry using microtip technology: a cohort study in 172 subjects.Int J Colorectal Dis2012
  • 1 - 50 of 536

Recommended Authors

Bagcilar Training and Research Hospital
Career Start Year 2009
Number of shared co-authors 0
Federico II University
Career Start Year 2007
Number of shared co-authors 0
The First Affiliated Hospital of Wenzhou Medical University
Career Start Year 2002
Number of shared co-authors 0
Keimyung University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 3
Medical University of Innsbruck
Career Start Year 1999
Number of shared co-authors 0
National Defense Medical College
Career Start Year 1997
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 1996
Number of shared co-authors 0
Surgical Outcomes Research Center, University of Virginia
Career Start Year 1996
Number of shared co-authors 0
Institute of Liver Transplantation
Career Start Year 1996
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 3
University of Florida Central Florida USA.
Career Start Year 1989
Number of shared co-authors 0
University of South Florida Morsani College of Medicine
Career Start Year 1989
Number of shared co-authors 0
University of Miyazaki
Career Start Year 1988
Number of shared co-authors 0
Mie University
Career Start Year 1988
Number of shared co-authors 0
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Career Start Year 1987
Number of shared co-authors 0
University of Minnesota
Career Start Year 1987
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 0
European Hospital Georges Pompidou, University of Paris Descartes
Career Start Year 1982
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1982
Number of shared co-authors 0
Hospital Clinico San Carlos
Career Start Year 1981
Number of shared co-authors 0
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1978
Number of shared co-authors 0
Medical University of Lubeck
Career Start Year 1977
Number of shared co-authors 0
University Medical Center Schleswig-Holstein
Career Start Year 1976
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1974
Number of shared co-authors 0
12349University of Virginia
Career Start Year 1972
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 1971
Number of shared co-authors 0
Medical University of Warsaw
Career Start Year 1969
Number of shared co-authors 0
University of Virginia, Surgical Outcomes Research Center
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Co-authored papers 4
Co-authored papers 3
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Co-authored papers 1
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 1
Co-authored papers 1
Clinic of Urology and Pediatric Urology, University of Saarland
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Saarland University
Co-authored papers 1
TU Dortmund University
Co-authored papers 1
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Clinic of Urology and Pediatric Urology, University of Saarland
Co-authored papers 1
Max-Planck-Institute for Informatics
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Clinical Trials Unit
Co-authored papers 1
Co-authored papers 1